NewZ NewZ with a Zeal
The $7.6bn takeover of Swedish rare disease company Sobi by private equity group Advent International and Singapore’s wealth fund failed to convince the 90% of shareholders needed
Tags AstraZeneca
Related Articles
Check Also
Asian shares fall after worst Wall Street day since 2020
Shares in Australia and Japan fell at the open. US equity-index futures were steady as …
Burnt Allies: Japan, S Korea Toe Cautious Line After Trump Tariffs
(MENAFN – Asia Times)Two months into US President Donald Trump’s second term, the liberal international …